HERON THERAPEUTICS, INC. recalls Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit,
Recalled August 24, 2022 · FDA recall D-1335-2022 · HERON THERAPEUTICS
Hazard
Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit · FDA Class III
Units
1790 kits
Sold at
U.S.A. Nationwide
Description
Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit
Product
Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactured for Heron Therapeutics, Inc., San Diego, CA, NDC 47426-301-02
Manufacturer(s)
HERON THERAPEUTICS, INC.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →